Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Prognostic Value of FP-CIT-SPECT in Patients With Parkinson´s Disease
Sponsor: Universität des Saarlandes
A observational or N/A phase clinical study on Parkinson´s Disease, this trial is completed. The trial is conducted by Universität des Saarlandes and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Feb 2021 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universität des Saarlandes
For direct contact, visit the study record on ClinicalTrials.gov .